Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PSMA-1-DOTA Potentially for Effective Targeted Radioligand Therapy of Prostate Cancer

Molecular Imaging and Biology(2025)10.1007/s11307-025-02046-9Source: DataRank Database

PSMA-1-DOTA Potentially for Effective Targeted Radioligand Therapy of Prostate Cancer is a research paper published in Molecular Imaging and Biology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.70)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Olga Sergeeva ORCID,Maxim Sergeev,Lifang Zhang ORCID,Zoey A. Lockwood,Patrick Wojtylak

Live enrichment

PubMed:40897948 PMC:PMC12628472 OpenAlex:https://openalex.org/W4413915530

National Cancer Institute

Grant: R01CA246678

National Cancer Institute

Grant: R01CA260847

National Cancer Institute

Grant: R01CA255925

DOD Peer Reviewed Cancer Research Program

Grant: W81XWH2210784

NIAID NIH HHS

Grant: R21 AI163656

FWCI

0.70

Citation Percentile

0.7%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s11307-025-02046-9.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11307-025-02046-9.pdf

publisherhttps://link.springer.com/article/10.1007/s11307-025-02046-9/fulltext.html

journalhttps://doi.org/10.1007/s11307-025-02046-9

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40897948

Fields of Study

Prostate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and TreatmentMaleAnimalsProstatic NeoplasmsHumansCell Line, TumorHeterocyclic Compounds, 1-RingLigandsMiceGallium RadioisotopesTissue DistributionRadiopharmaceuticalsXenograft Model Antitumor AssaysGlutamate Carboxypeptidase IIPositron Emission Tomography Computed TomographyMice, Nude

MeSH Terms

Positron Emission Tomography Computed TomographyAnimalsGallium RadioisotopesHeterocyclic Compounds, 1-RingHumansLigandsMaleMice, NudeProstatic NeoplasmsTissue DistributionRadiopharmaceuticalsXenograft Model Antitumor AssaysGlutamate Carboxypeptidase IICell Line, TumorMice

Keywords

DOTARadioligandProstate cancerMedicineCancer researchGlutamate carboxypeptidase IINuclear medicineIn vivoCancerInternal medicineReceptorBiologyPsmaDry MouthTargeted Radioligand Therapy